Ronald G. Jubin
Technik-/Wissenschafts-/F&E-Leiter bei Prolong Pharmaceuticals LLC
Profil
Ronald G.
Jubin is currently the Vice President of Research & Development at Prolong Pharmaceuticals LLC since 2013.
Prior to this, he worked as a Principal at Schering-Plough Research Institute.
He holds a doctorate degree from New Jersey Medical School.
Aktive Positionen von Ronald G. Jubin
| Unternehmen | Position | Beginn |
|---|---|---|
Prolong Pharmaceuticals LLC
 Prolong Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 18.12.2013 |
Ehemalige bekannte Positionen von Ronald G. Jubin
| Unternehmen | Position | Ende |
|---|---|---|
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Ausbildung von Ronald G. Jubin
| New Jersey Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Prolong Pharmaceuticals LLC
Prolong Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ. | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
